If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following:

  • Preclinical and clinical phase oligos and peptides: case studies
  • Oligo discovery (new modalities, long oligos, aptamers, siRNA, new modifications, new biology)
  • Oligonucleotide manufacturing/CMC (processes, scale-up, improved yield/quality, control)
  • Peptide discovery (generics, new modalities, hybrids, modifications, cocktails, immunotherapies)
  • Peptide manufacturing/CMC (process, analytics, QC, raw materials, supply chain, technology)
  • GLP-1 Landscape: pipeline advances and new delivery approaches
  • Impurity profiling, qualification, control strategies; genotix impurities
  • mRNA or CRISPR Therapeutic Discovery and CMC Strategies, Impurity Profiling
  • Analytics, bioanalysis and control ctrategies for peptides, oligos, mRNA, CRISPR
  • Personalized medicine-based oligos and peptides; Peptide vaccines, Rare disease strategies
  • Regulatory strategies, experiences and guidances for oligos and peptides, IND/IMPD strategies
  • Green chemistry / Sustainable chemistry/ Environmental sustainability
  • Conjugation strategies (GalNAc, targeting, oligo-peptide conjugates)
  • Novel chemistries and synthesis (chirality, peptide chemistry, optimization, new modifications)
  • Drug Delivery (targeting, carriers, mode of admin., devices, endosomal escape, cell-penetration)
  • Formulation strategies (Lipid nanoparticles, peptide formulations, controlled release)
  • Nonclinical (tox, PK, safety, off-target) development strategies and case studies
  • Drug product development strategies for oligonucleotides and peptides

Submit a Proposal

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

You will be notified by the Event Review Committee if your presentation has been selected.

Call for Speakers

Please Submit Your Speaking Proposal by Filling Out the Form Below 

TIDES: Oligonucleotide and Peptide Therapeutics

May 20-23, 2019
Manchester Grant Hyatt,

San Diego, CA

View our Privacy Policy

Fix the following errors: